Homepage Flash

CorMatrix ECM Technology has been used at more than 300 hospitals across the U.S. and has been implanted in nearly 20,000 cardiac procedures.

This naturally occurring extracellular matrix biomaterial supports native tissue repair by providing an interim bioscaffold, that enables a patient's own cells to repopulate and repair damaged tissues.

Watch how ECM Technology helps repair damaged heart tissue

Launch Video

January 25-27, 2010
Fort Lauderdale, FL

Society of Thoracic Surgeons (STS) 46th Annual Meeting »

February 21-24, 2010
Snowbird, UT

18th Utah Conference on Congenital Cardiovascular Disease »

March 14-16, 2010
Atlanta, GA

American College of Cardiology (ACC) Annual Meeting »

CorMatrix ECM Video

CorMatrix is dedicated to developing and delivering unique extracellular matrix (ECM™) biomaterial technologies that harness the body's innate ability to repair damaged cardiovascular tissue.